KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 98 filers reported holding KALVISTA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,423,502 | +10.2% | 459,346 | +3.0% | 0.00% | – |
| Q2 2023 | $4,015,575 | +21.9% | 446,175 | +6.4% | 0.00% | – |
| Q1 2023 | $3,295,391 | -39.7% | 419,261 | -48.1% | 0.00% | – |
| Q4 2022 | $5,461,540 | -10.8% | 807,920 | +91.5% | 0.00% | – |
| Q3 2022 | $6,121,000 | +51.6% | 421,819 | +2.8% | 0.00% | – |
| Q2 2022 | $4,037,000 | -70.8% | 410,252 | -56.3% | 0.00% | -100.0% |
| Q1 2022 | $13,839,000 | -0.6% | 938,867 | -10.8% | 0.00% | 0.0% |
| Q4 2021 | $13,918,000 | -23.6% | 1,051,976 | +0.8% | 0.00% | 0.0% |
| Q3 2021 | $18,215,000 | -45.7% | 1,043,828 | -25.5% | 0.00% | -50.0% |
| Q2 2021 | $33,556,000 | +120.8% | 1,400,501 | +136.8% | 0.00% | +100.0% |
| Q1 2021 | $15,195,000 | +198.9% | 591,472 | +121.0% | 0.00% | – |
| Q4 2020 | $5,083,000 | +54.9% | 267,654 | +2.7% | 0.00% | – |
| Q3 2020 | $3,281,000 | +7.7% | 260,565 | +3.5% | 0.00% | – |
| Q2 2020 | $3,046,000 | +62.5% | 251,770 | +2.8% | 0.00% | – |
| Q1 2020 | $1,874,000 | -54.6% | 245,001 | +5.6% | 0.00% | – |
| Q4 2019 | $4,131,000 | +56.1% | 231,941 | +1.7% | 0.00% | – |
| Q3 2019 | $2,647,000 | -40.5% | 228,151 | +13.6% | 0.00% | – |
| Q2 2019 | $4,448,000 | +1715.5% | 200,826 | +2242.0% | 0.00% | – |
| Q1 2019 | $245,000 | – | 8,575 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $38,088,000 | 25.57% |
| VHCP Management III, LLC | 637,884 | $14,129,000 | 6.60% |
| Vivo Capital, LLC | 1,359,149 | $30,105,000 | 2.82% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $8,611,000 | 2.78% |
| VHCP Management II, LLC | 376,889 | $8,348,000 | 2.63% |
| Samsara BioCapital, LLC | 118,500 | $2,625,000 | 1.73% |
| ACUTA CAPITAL PARTNERS, LLC | 213,000 | $4,718,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 187,599 | $4,165,000 | 1.54% |
| Ghost Tree Capital, LLC | 300,000 | $6,645,000 | 1.38% |
| Eventide Asset Management | 1,500,000 | $33,225,000 | 1.01% |